Back to search

Article

CDDO-Imidazole regulates RBC alloimmunization to the KEL antigen by activating Nrf2

2025-04-06

Abstract excerpt

During red blood cell (RBC) transfusion, production of alloantibodies can promote significant hemolytic events. However, most transfusion recipients do not form anti-RBC alloantibodies. Identifying mechanisms that inhibit alloimmunization may lead to prophylactic interventions. One potential regulatory mechanism is activation of the transcription factor, nuclear factor erythroid-derived 2-like 2 (Nrf2), a master r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
98293693-786b-5838-9879-6bb648a91f93
DOI
10.1101/2025.04.03.645598
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CDDO-Imidazole regulates RBC alloimmunization to the KEL antigen by activating Nrf2DOI 10.1101/2025.04.03.645598
Select a neighboring publication to make it the new centre.